Supplemental material
Open access
2,377
Views
5
CrossRef citations to date
0
Altmetric
Immunotherapeutics – Research Article
Advancing humanized monoclonal antibody for counteracting fentanyl toxicity towards clinical development
Dustin Hicksa Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA
https://orcid.org/0000-0002-6934-4050View further author information
Carly Baehra Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA
https://orcid.org/0000-0002-3395-6776View further author information
Pedro Silva-Ortiza Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA
https://orcid.org/0000-0001-6135-9111View further author information
Aaron Khaimraja Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA
https://orcid.org/0000-0002-2588-0900View further author information
Diego Luengasa Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA
https://orcid.org/0000-0002-4550-841XView further author information
Fatima A. Hamida Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA
https://orcid.org/0000-0003-3496-2104View further author information
Marco Pravetonia Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA;b Center for Immunology, University of Minnesota, Minneapolis, MN, USA;c School of Medicine, Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USACorrespondence[email protected]
https://orcid.org/0000-0003-1036-0184View further author information
Article: 2122507
|
Received 27 Jun 2022, Accepted 04 Sep 2022, Published online: 04 Oct 2022
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.